Search research articles
Contact Us
Filters
Showing results (1-10 of 207) with videos related to
Page
of 21
Sort By:
The Canadian Journal of Cardiology
|
July 13, 2013
Trainees: the lifeblood and future of CCS
Mario Talajic
The Canadian Journal of Cardiology
|
October 22, 2005
Drug therapy for termination of atrial fibrillation and maintenance of sinus rhythm
Mario Talajic, Denis Roy
Chaos (Woodbury, N.Y.)
|
October 1, 1991
Dynamics of heart rate
Daniel T. Kaplan, Mario Talajic
The Canadian Journal of Cardiology
|
June 15, 2005
Implanted cardioverter defibrillators for the prevention of sudden death
Paul Dorian, Mario Talajic, Anthony Tang
Heart Rhythm
|
July 2, 2017
Risk of arrhythmic events in drug-induced Brugada syndrome
Najim Lahrouchi, Mario Talajic, Rafik Tadros
The Canadian Journal of Cardiology
|
December 23, 2014
A look into the future of cardiology: perspectives from the Montreal Heart Institute
Stanley Nattel, Mario Talajic, Jean-Claude Tardif
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC
|
December 13, 2012
Long QT syndrome in pregnancy: are vaginal delivery and use of oxytocin permitted? A case report
Gabriella Martillotti, Mario Talajic, Eveline Rey, et al.
Heart Rhythm
|
May 2, 2006
Pacemaker troubleshooting: when MVP is not the most valuable parameter
Fadi Mansour, Mario Talajic, Bernard Thibault, et al.
Cardiac Electrophysiology Review
|
January 24, 2004
Cost evaluation of rhythm control methods for atrial fibrillation: evidence from CTAF
Stanley Nattel, Gerald Lumer, Mario Talajic, et al.
Heart Rhythm
|
February 17, 2010
Dormant pulmonary vein conduction unmasked by external electrical cardioversion
Irina Horduna, Stanley Nattel, Mario Talajic, et al.
Page
of 21
Search research articles
Search
Showing results (1-10 of 207) with videos related to
Sort By:
Page
of 21
The Canadian Journal of Cardiology
|
July 13, 2013
Trainees: the lifeblood and future of CCS
Mario Talajic
The Canadian Journal of Cardiology
|
October 22, 2005
Drug therapy for termination of atrial fibrillation and maintenance of sinus rhythm
Mario Talajic, Denis Roy
Chaos (Woodbury, N.Y.)
|
October 1, 1991
Dynamics of heart rate
Daniel T. Kaplan, Mario Talajic
The Canadian Journal of Cardiology
|
June 15, 2005
Implanted cardioverter defibrillators for the prevention of sudden death
Paul Dorian, Mario Talajic, Anthony Tang
Heart Rhythm
|
July 2, 2017
Risk of arrhythmic events in drug-induced Brugada syndrome
Najim Lahrouchi, Mario Talajic, Rafik Tadros
The Canadian Journal of Cardiology
|
December 23, 2014
A look into the future of cardiology: perspectives from the Montreal Heart Institute
Stanley Nattel, Mario Talajic, Jean-Claude Tardif
Journal of Obstetrics and Gynaecology Canada : JOGC = Journal D'Obstetrique Et Gynecologie Du Canada : JOGC
|
December 13, 2012
Long QT syndrome in pregnancy: are vaginal delivery and use of oxytocin permitted? A case report
Gabriella Martillotti, Mario Talajic, Eveline Rey, et al.
Heart Rhythm
|
May 2, 2006
Pacemaker troubleshooting: when MVP is not the most valuable parameter
Fadi Mansour, Mario Talajic, Bernard Thibault, et al.
Cardiac Electrophysiology Review
|
January 24, 2004
Cost evaluation of rhythm control methods for atrial fibrillation: evidence from CTAF
Stanley Nattel, Gerald Lumer, Mario Talajic, et al.
Heart Rhythm
|
February 17, 2010
Dormant pulmonary vein conduction unmasked by external electrical cardioversion
Irina Horduna, Stanley Nattel, Mario Talajic, et al.
Page
of 21